KAREN VERRILL: Open Payments
NPI 1780684340 · KANKAKEE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 26 payments from 19 companies in 2025. Trend: 2023 $311 · 2024 $183 · 2025 $709
Food & beverage: $516Education: $193
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 2 | $123 |
| SANOFI-AVENTIS U.S. LLC | 1 | $93 |
| ABBVIE INC. | 2 | $65 |
| Celgene Corporation | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Janssen Biotech, Inc. | 2 | $37 |
| JAZZ PHARMACEUTICALS INC. | 1 | $29 |
| Genentech USA, Inc. | 1 | $22 |
| Genmab U.S., Inc. | 1 | $22 |
Products named: SARCLISA, REBLOZYL, OPDIVO, VENCLEXTA, Fabhalta, ELAHERE, ZEPZELCA, KISQALI.
Industry payments across IL — which companies pay providers there.
